BlueGnome was founded in Cambridge in 2002 by a team of scientists who developed a novel mathematical technology for the analysis of genetic data following the sequencing of the human genome in 2000.
With the support of the University of Cambridge and the Wellcome Trust, BlueGnome released in 2006 the CytoChip – a powerful new approach for the investigation of genetic abnormalities. The CytoChip is now used in over 40 countries world wide. Over 50,000 samples have been investigated using the CytoChip, mainly associated with developmental delay or with complex leukaemias. It is now used in over 200 labs.
